List of works - Paul Neeson

A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

scientific article

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

scientific article published on 12 January 2017

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

scientific article

A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice

scientific article published on 12 November 2014

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

scientific article published on 27 March 2008

Adoptive immunotherapy: a new era for the treatment of cancer

scientific article published on 01 January 2015

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

scientific article published on 19 September 2017

Allogeneic CAR19 cells clear ALL

scientific article published on 01 March 2016

Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome

scientific article published on 01 February 1998

Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?

scientific article published on May 2012

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21

scientific article

Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue

scientific article published on 30 May 2018

Biology and clinical observations of regulatory T cells in cancer immunology

scientific article published on January 2011

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

scientific article published on 07 June 2021

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

scientific article

CAR-T cells are serial killers

scientific article

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells

scientific article published on 11 November 2014

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

scientific article published on 16 August 2017

Characterization of activated lymphocyte-tumor cell adhesion.

scientific article

Characterization of the treatment-naive immune microenvironment in melanoma with <i>BRAF</i> mutation

scientific article published on 01 April 2022

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

scientific article published on 12 February 2018

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

scientific article published in June 2013

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin

scientific article published on 01 January 2000

Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

scientific article published on 01 May 1999

Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition

scientific article

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

scientific article published on 13 December 2016

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

scientific article published in August 2000

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

scientific article

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

scientific article published on January 2006

Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression

scientific article published on June 2015

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

scientific article published on 7 March 2018

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

scientific article published on 29 April 2010

Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry

scientific article published on 09 March 2018

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

scientific article published on 4 March 2010

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

scientific article published on 01 June 2020

High mammographic density in women is associated with protumor inflammation

scientific article published on 09 August 2018

High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer

scientific article published on 05 May 2020

Human blood MAIT cell subsets defined using MR1 tetramers.

scientific article published on 13 February 2018

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

scientific article published on 17 July 2018

Immunological battlefield in gastric cancer and role of immunotherapies

scientific article

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

scientific article

LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins

scientific article published on 03 June 2018

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

scientific article

Lymphocyte-facilitated tumour cell adhesion to endothelial cells: the role of high affinity leucocyte integrins

scientific article published on February 2003

MAIT cells regulate NK cell-mediated tumor immunity

scientific article published on 06 August 2021

Manipulating immune cells for adoptive immunotherapy of cancer

scientific article published on 15 February 2014

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

scientific article

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

scientific article published on 24 July 2018

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss

scientific article published on 01 May 2015

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

scientific article published in January 2014

OMIP-021: Simultaneous quantification of human conventional and innate-like T-cell subsets

scientific article published on 22 April 2014

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

scientific article published on 08 May 2017

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

scientific article published on 08 July 2013

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

scientific article published on 01 December 2018

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy

scientific article

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

scientific article published on 14 January 2010

The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort.

scientific article published on 25 September 2017

The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells

scientific article published on 16 June 2009

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

scientific article published on March 2004

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.

scientific article

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

scientific article published on 26 October 2010

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

scientific article published on 19 October 2010

The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

scientific article published on 09 February 2016

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

scientific article published on 01 May 2022

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

scientific article published on 23 November 2010

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

scientific article published on 6 October 2004

List of works by Paul Neeson

A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

Adoptive immunotherapy: a new era for the treatment of cancer

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

Allogeneic CAR19 cells clear ALL

Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome

Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21

Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue

Biology and clinical observations of regulatory T cells in cancer immunology

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

CAR-T cells are serial killers

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Characterization of activated lymphocyte-tumor cell adhesion.

Characterization of the treatment-naive immune microenvironment in melanoma with <i>BRAF</i> mutation

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin

Detection of anti-phosphatidylethanolamine antibodies using flow cytometry

Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.

Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

High mammographic density in women is associated with protumor inflammation

High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer

Human blood MAIT cell subsets defined using MR1 tetramers.

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

Immunological battlefield in gastric cancer and role of immunotherapies

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.

Lymphocyte-facilitated tumour cell adhesion to endothelial cells: the role of high affinity leucocyte integrins

MAIT cells regulate NK cell-mediated tumor immunity

Manipulating immune cells for adoptive immunotherapy of cancer

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

OMIP-021: Simultaneous quantification of human conventional and innate-like T-cell subsets

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort.

The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells

The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.